In this study we have identified several features that affect RTX-mediated CDC in B-cell lymphoma; CD20 antigen density, CD59 expression level, tumor structure, and choice of mAb isotype. This evidence concerns the gene CD59 and B-cell non-Hodgkin lymphoma.